BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2016

Jun 9, 2016

SEC Form 4/A — Form 4/A

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2016-05-31

Reporting Person: SPIEGELMAN DANIEL K (EVP, Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-31	Stock Option (Right to buy) Common Stock	$39.06	M	16896	Disposed	2022-05-28	Common Stock (16896)	Direct

Footnotes

F1: This amendment is being filed solely to correct the fact that the original filing inadvertently stated that the securities were acquired when in fact they were disposed of in this transaction.

F2: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.